How to dilute Atrovent (ipratropium bromide) for use in a nebulizer for children under 2 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atrovent Nebulization Dosing for Children Under 2 Years

For children under 2 years old, use ipratropium bromide 100-125 mcg (half the standard pediatric dose) via nebulizer, diluted to a minimum of 3 mL total volume with normal saline for optimal nebulization. 1

Specific Dilution Instructions

  • Start with 100-125 mcg of ipratropium bromide solution (this is half the standard pediatric dose of 250 mcg) 2, 1
  • Dilute to a minimum total volume of 3 mL using normal saline to ensure adequate nebulization 1
  • For infants with bronchopulmonary dysplasia requiring ventilation, doses as low as 75-125 mcg have been studied, with 125 mcg showing efficacy 3
  • In pre-term babies, doses exceeding 20 mcg may produce side effects, so extreme caution is warranted in this population 4

Administration Protocol

Initial Treatment for Acute Wheezing/Asthma

  • Administer every 20 minutes for the first 3 doses when treating acute severe asthma or wheezing 1
  • Then continue every 6 hours until clinical improvement begins 2, 1
  • Use an oxygen-driven nebulizer at 6-8 L/min flow rate 1
  • Ensure proper pediatric mask fit to maximize medication delivery 5

Clinical Context for Use

  • Add ipratropium to beta-agonist therapy (not as monotherapy) in very young children who are not improving after 15-30 minutes of initial beta-agonist treatment 2, 1
  • Ipratropium can be particularly useful in the first 18 months of life when beta-2 agonists are often less effective 4
  • Approximately 40% of young children with recurrent airways obstruction obtain significant benefit 4

Combination Therapy Option

  • Ipratropium can be mixed with albuterol/salbutamol in the same nebulizer solution 1
  • For children under 5 years using combination therapy (Duolin), use 1.5 mL of solution containing 0.25 mg ipratropium + 1.25 mg salbutamol 5
  • Studies in infants under 25 months showed combination therapy (fenoterol + 50 mcg ipratropium) was significantly more effective than beta-agonist alone (63.4% vs 25.8% improvement) 6

Important Safety Considerations

  • Monitor for dry mouth and respiratory secretions as common side effects 5
  • Watch for paradoxical increased wheezing in some individuals 5
  • In ventilated infants with BPD, doses of 125-175 mcg combined with salbutamol showed significant improvements in respiratory mechanics at 1-2 hours and 4 hours post-administration 3
  • Metered-dose aerosol with spacer and mask is equally effective as nebulization in this age group and may be more convenient 7

Key Clinical Pitfalls to Avoid

  • Never use ipratropium as first-line monotherapy in acute exacerbations—always combine with beta-agonists 1, 5
  • Do not exceed the half-dose recommendation (100-125 mcg) in very young children, as the British Thoracic Society specifically emphasizes dose reduction for this age group 2, 1
  • Ensure adequate dilution volume (minimum 3 mL) to prevent inadequate nebulization and suboptimal drug delivery 1

References

Guideline

Bromuro de Ipratropio Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ipratropium bromide and airways obstruction in childhood.

Postgraduate medical journal, 1987

Guideline

Duolin Dosage and Administration Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ipratropium bromide delivered by metered-dose aerosol to infant wheezers.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.